Profile data is unavailable for this security.
About the company
Fidson Healthcare Plc is a Nigeria-based pharmaceutical manufacturing company. The principal activities of the Company include the manufacturing and distribution of pharmaceutical products. The Company's segments include over-the-counter, ethical products, and consumer healthcare. The over-the-counter segment represents the products that may be sold directly to the consumer without a prescription. The ethical products segment represents drugs, injectables and infusions, which are sold to the consumer only on the possession of a valid prescription. The consumer segment represents manufacturing products for customers. It provides services, including formulation/development, contract manufacturing, and production of medicines. Its products include Anti-Infective and Anti-Malaria, Central Nervous System, Gastrointestinal Medicines, Topical/Dermatological Medicines, Vitamins and Minerals, Ophthalmic Solution, and others. Its Ophthalmic Solution helps manage and treat eye conditions.
- Revenue in NGN (TTM)119.06bn
- Net income in NGN9.31bn
- Incorporated1995
- Employees674.00
- LocationFidson Healthcare PLC268, Ikorodu Road, ShomoluP.O.Box 7210LAGOS NigeriaNGA
- Phone+234 3429102
- Fax+234 3429106
- Websitehttps://www.fidson.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 55.98bn | -28.65bn | 206.47bn | 77.00 | -- | -- | -- | 3.69 | -0.0177 | -0.0177 | 0.0334 | -0.0105 | 0.7624 | 3.98 | 2.12 | 395,517.40 | -39.02 | -60.44 | -131.46 | -78.58 | 48.34 | 50.99 | -51.18 | -212.62 | 0.6922 | -2.50 | 2.22 | -- | 145.93 | 103.70 | 18.36 | -- | 6.51 | -- |
| T Man Pharmaceutical PCL | 102.02bn | 19.48bn | 208.03bn | 960.00 | 10.68 | 2.48 | 8.43 | 2.04 | 1.12 | 1.12 | 5.88 | 4.84 | 0.754 | 2.03 | 3.64 | 2,452,049.00 | 14.40 | -- | 33.57 | -- | 47.67 | -- | 19.09 | -- | 0.9128 | 17.38 | 0.3316 | -- | 12.19 | -- | 4.55 | -- | -- | -- |
| Mayne Pharma Group Ltd | 393.94bn | -85.91bn | 210.01bn | 450.00 | -- | 0.5946 | -- | 0.5331 | -1.14 | -1.19 | 5.22 | 4.56 | 0.3828 | 2.57 | 2.42 | 917,797.80 | -8.35 | -15.32 | -11.61 | -20.87 | 61.06 | 53.04 | -21.81 | -64.51 | 1.16 | -- | 0.1003 | -- | 4.44 | -2.04 | 46.58 | -- | -9.26 | -- |
| Ngl Fine Chem Ltd | 66.39bn | 5.26bn | 210.14bn | 456.00 | 39.98 | -- | 26.57 | 3.17 | 57.26 | 57.26 | 723.35 | -- | -- | -- | -- | 9,799,871.00 | -- | 13.34 | -- | 17.44 | 51.62 | 41.63 | 7.92 | 12.15 | -- | 9.06 | -- | 2.85 | 8.73 | 19.41 | -48.87 | 20.44 | 53.91 | 0.00 |
| Fidson Healthcare PLC | 119.06bn | 9.31bn | 211.33bn | 674.00 | 19.03 | 5.44 | 18.30 | 1.78 | 3.84 | 3.84 | 48.81 | 13.41 | 1.55 | 2.77 | 13.82 | -- | 12.09 | 10.02 | 26.14 | 19.32 | 41.28 | 41.98 | 7.82 | 8.12 | 0.5243 | 2.13 | 0.5217 | -- | 41.42 | 45.47 | 61.05 | 50.51 | 31.56 | -- |
| Botanix Pharmaceuticals Ltd | 5.49bn | -82.41bn | 211.40bn | 1.00 | -- | 2.71 | -- | 38.50 | -0.0466 | -0.0466 | 0.0031 | 0.0415 | 0.0477 | 0.2477 | 3.48 | -- | -71.53 | -50.27 | -81.16 | -56.02 | 36.99 | -- | -1,500.65 | -1,888.17 | 2.87 | -- | 0.2226 | -- | 856.64 | 102.14 | -522.91 | -- | 63.43 | -- |
| Ste Promotion Pharmaceutique du Mghrb SA | 137.32bn | 8.45bn | 212.11bn | -- | 25.09 | 2.49 | 12.51 | 1.54 | 57.20 | 57.20 | 928.99 | 575.64 | 0.7791 | 1.38 | 3.90 | -- | 4.80 | 8.48 | 7.50 | 12.35 | 44.33 | 48.51 | 6.16 | 8.76 | 0.9687 | 16.40 | 0.2975 | -- | 11.57 | 11.46 | -3.05 | 1.14 | 44.62 | -- |
| Karyopharm Therapeutics Inc | 197.00bn | -264.40bn | 212.28bn | 228.00 | -- | -- | -- | 1.08 | -16.60 | -16.60 | 13.36 | -16.00 | 1.07 | 1.36 | 5.13 | 640,644.80 | -143.71 | -55.11 | -442.98 | -78.19 | 95.93 | 96.83 | -134.21 | -87.65 | 1.08 | -2.11 | 47.44 | -- | 0.5715 | 6.21 | -156.52 | -- | -- | -- |
| Renascience Inc | 939.57m | -2.28bn | 212.45bn | 3.00 | -- | 9.81 | -- | 226.11 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| Kotra Industries Berhad | 79.63bn | 14.51bn | 214.40bn | 713.00 | 14.77 | 2.21 | 11.12 | 2.69 | 0.283 | 0.283 | 1.55 | 1.89 | 0.6767 | -- | 6.51 | 322,946.70 | 12.33 | 15.69 | 14.64 | 18.97 | -- | 74.23 | 18.23 | 22.38 | 1.68 | 1,900.70 | 0.0797 | 53.35 | 1.87 | 6.09 | -4.76 | 7.52 | 72.15 | 23.16 |
